home login careers contact sitemap help
pharmacom index.htm
Products Analysis Support Technology Corporate
Biopharmaceutical
Target Identification
Preclinical Studies
Clinical Trials
Regulatory Affairs
Biotechnology
DNA-based biosensors
RNA-based biosensors
Protein-based biosensors
Immuno biosensors
Cell-based biosensors
Microbial biosensors
Optic biosensors
Electronic biosensors
Nano-scaled biosensors
Biodefense
Therapeutics
Vaccines
Adjuvants/Immuostimulants
Diagnostics
Prevention
Bioinformatics
Genomics
Proteomics
Functional Genomics
Structural Genomics
Bioterrorism is defined as the use of microorganisms that cause human disease, or the toxins released from them, to harm people or elicit widespread fear or intimidation of society. Biological/Chemical weapons are devices to deliberately disseminate disease producing organisms or toxins in food, water, insect vector and an aerosol.

Public health officials, medical personnel, firefighters, military and other law enforcement need to be able to identify the most threatening of the biological weapons, specially those that require preparedness measures.

A number of of Pharmacom's initiatives is to identify the correct medical response under the diverse mode of biological attacks. We focus on emerging infectious disease research, including research on pathogens that can be used as agents of bioterrorism. Biodefense research is similar to other emerging infectious diseases. It entails research to understand the pathogenesis of these microbes, how the host responds to them, and the translation of this knowledge into useful treatments, diagnostics, and vaccines.

The following diagram shows the effects of a nuclear and biological weapons release.

Resources
Technical Bulletins
Pharmacom Copyright 1997-2003 Feedback